The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> November 27, 2015

Interview with the Director of Corporate Development and U.S. Representative: Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)

Cramer, R. Scott
R. Scott Cramer is a member of the board of directors of Skystar Bio-Pharmaceutical Company, Director of Corporate Development and U.S. Representative. He has been with the company since its public inception in 2005 and has played an integral role in Skystar’s listing on Nasdaq in March 2009. Previously, Mr. Cramer served as Chairman and Chief Executive Officer of The Cyber Group Corporation, a publicly traded company, from November 2001 to November 2005 and as its Chief Financial Officer from April 2003 to November 2005. Mr. Cramer is the Founder and President of Cramer & Rauchegger, an independent financial advisory firm specializing in retirement management, estate planning and wealth management. In 2013, the firm was ranked amongst the top-three financial planning firms in central Florida by the Orlando Business Journal and listed as one of Orlando’s top wealth management firms by the National Association of Board Certified Advisory Practices, who also awarded the firm first place in the category of risk management. Mr. Cramer’s expertise and opinions have been frequently sought after by various television, print, wire and online media outlets, such as Bloomberg TV, CNBC, Fox Business, Smart Money, Dow Jones Newswire, Reuters, Bankrate.com, AOL DailyFinance and many others. Mr. Cramer has more than 30 years of experience as a financial adviser; his credentials include Chartered Retirement Planning Counselor, certified estate planning professional and a certified annuity adviser. Profile
TWST: How was Skystar formed?

Mr. Cramer: Skystar is a manufacturer of vaccines, medicines, feed additives and probiotics. Back in 2005, Skystar wanted access to the capital markets, so

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy